Antibacterial properties of additives used in injection immunotherapy

Kevin C. Gilbert, Vidya Sundareshan, Richard M. Bass, Sandra Y Lin

Research output: Contribution to journalArticle

Abstract

Background: Previous studies have reviewed the safety of preparing and administering allergy injection immunotherapy in a physician's office, and showed no evidence of infectious complications. The current study examines the antimicrobial properties of the common additives used in preparation of multidose immunotherapy vials. Methods: Vials were prepared with varying concentrations of glycerin (0-25%), phenol (0-0.4%) and combinations of glycerin with phenol. A standard inoculum of Staphylococcus aureus was introduced in each vial and incubated. Optical densities were measured and colony counts were performed at 24 and 48 hours. Follow-up broth microdilution assays were performed using varying inocula of bacteria and the highest concentrations of additives to determine the number of bacteria for which these solutions were bacteriostatic and/or bactericidal. Optical densities weremeasured and colony counts were performed as in the vial assays. Results: All vials with varying dilutions of glycerin, phenol, and their combination showed bacterial growth with the standard inoculum of Staphylococcus aureus. Visible turbidity and optical density were inversely related to additive concentration. Follow-up microdilution assays with differing concentrations of bacteria demonstrated bactericidal activity with inocula of 1×10 3 colony forming units (CFU) of Staphylococcus aureus at clinically used concentrations of glycerin and phenol. Conclusion: Higher concentrations of additives show better inhibition of bacterial growth. Solutions containing glycerin showed superior bactericidal activity than those containing only phenol. At concentrations of additives used in preparing allergy immunotherapy vials, antibacterial effects were observed with inoculation of 1×10 3 CFU or less of Staphylococcus aureus.

Original languageEnglish (US)
Pages (from-to)135-138
Number of pages4
JournalInternational Forum of Allergy and Rhinology
Volume2
Issue number2
DOIs
StatePublished - Mar 2012

Fingerprint

Phenol
Immunotherapy
Glycerol
Staphylococcus aureus
Injections
Bacteria
Hypersensitivity
Stem Cells
Physicians' Offices
Growth
Safety

Keywords

  • Cutaneous drug administration
  • Drug preparation
  • Immunologic densitization
  • Immunotherapy
  • In vitro
  • Risk assessment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Antibacterial properties of additives used in injection immunotherapy. / Gilbert, Kevin C.; Sundareshan, Vidya; Bass, Richard M.; Lin, Sandra Y.

In: International Forum of Allergy and Rhinology, Vol. 2, No. 2, 03.2012, p. 135-138.

Research output: Contribution to journalArticle

Gilbert, Kevin C. ; Sundareshan, Vidya ; Bass, Richard M. ; Lin, Sandra Y. / Antibacterial properties of additives used in injection immunotherapy. In: International Forum of Allergy and Rhinology. 2012 ; Vol. 2, No. 2. pp. 135-138.
@article{763f036cf99241149d4c58113bd9fd58,
title = "Antibacterial properties of additives used in injection immunotherapy",
abstract = "Background: Previous studies have reviewed the safety of preparing and administering allergy injection immunotherapy in a physician's office, and showed no evidence of infectious complications. The current study examines the antimicrobial properties of the common additives used in preparation of multidose immunotherapy vials. Methods: Vials were prepared with varying concentrations of glycerin (0-25{\%}), phenol (0-0.4{\%}) and combinations of glycerin with phenol. A standard inoculum of Staphylococcus aureus was introduced in each vial and incubated. Optical densities were measured and colony counts were performed at 24 and 48 hours. Follow-up broth microdilution assays were performed using varying inocula of bacteria and the highest concentrations of additives to determine the number of bacteria for which these solutions were bacteriostatic and/or bactericidal. Optical densities weremeasured and colony counts were performed as in the vial assays. Results: All vials with varying dilutions of glycerin, phenol, and their combination showed bacterial growth with the standard inoculum of Staphylococcus aureus. Visible turbidity and optical density were inversely related to additive concentration. Follow-up microdilution assays with differing concentrations of bacteria demonstrated bactericidal activity with inocula of 1×10 3 colony forming units (CFU) of Staphylococcus aureus at clinically used concentrations of glycerin and phenol. Conclusion: Higher concentrations of additives show better inhibition of bacterial growth. Solutions containing glycerin showed superior bactericidal activity than those containing only phenol. At concentrations of additives used in preparing allergy immunotherapy vials, antibacterial effects were observed with inoculation of 1×10 3 CFU or less of Staphylococcus aureus.",
keywords = "Cutaneous drug administration, Drug preparation, Immunologic densitization, Immunotherapy, In vitro, Risk assessment",
author = "Gilbert, {Kevin C.} and Vidya Sundareshan and Bass, {Richard M.} and Lin, {Sandra Y}",
year = "2012",
month = "3",
doi = "10.1002/alr.20105",
language = "English (US)",
volume = "2",
pages = "135--138",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Antibacterial properties of additives used in injection immunotherapy

AU - Gilbert, Kevin C.

AU - Sundareshan, Vidya

AU - Bass, Richard M.

AU - Lin, Sandra Y

PY - 2012/3

Y1 - 2012/3

N2 - Background: Previous studies have reviewed the safety of preparing and administering allergy injection immunotherapy in a physician's office, and showed no evidence of infectious complications. The current study examines the antimicrobial properties of the common additives used in preparation of multidose immunotherapy vials. Methods: Vials were prepared with varying concentrations of glycerin (0-25%), phenol (0-0.4%) and combinations of glycerin with phenol. A standard inoculum of Staphylococcus aureus was introduced in each vial and incubated. Optical densities were measured and colony counts were performed at 24 and 48 hours. Follow-up broth microdilution assays were performed using varying inocula of bacteria and the highest concentrations of additives to determine the number of bacteria for which these solutions were bacteriostatic and/or bactericidal. Optical densities weremeasured and colony counts were performed as in the vial assays. Results: All vials with varying dilutions of glycerin, phenol, and their combination showed bacterial growth with the standard inoculum of Staphylococcus aureus. Visible turbidity and optical density were inversely related to additive concentration. Follow-up microdilution assays with differing concentrations of bacteria demonstrated bactericidal activity with inocula of 1×10 3 colony forming units (CFU) of Staphylococcus aureus at clinically used concentrations of glycerin and phenol. Conclusion: Higher concentrations of additives show better inhibition of bacterial growth. Solutions containing glycerin showed superior bactericidal activity than those containing only phenol. At concentrations of additives used in preparing allergy immunotherapy vials, antibacterial effects were observed with inoculation of 1×10 3 CFU or less of Staphylococcus aureus.

AB - Background: Previous studies have reviewed the safety of preparing and administering allergy injection immunotherapy in a physician's office, and showed no evidence of infectious complications. The current study examines the antimicrobial properties of the common additives used in preparation of multidose immunotherapy vials. Methods: Vials were prepared with varying concentrations of glycerin (0-25%), phenol (0-0.4%) and combinations of glycerin with phenol. A standard inoculum of Staphylococcus aureus was introduced in each vial and incubated. Optical densities were measured and colony counts were performed at 24 and 48 hours. Follow-up broth microdilution assays were performed using varying inocula of bacteria and the highest concentrations of additives to determine the number of bacteria for which these solutions were bacteriostatic and/or bactericidal. Optical densities weremeasured and colony counts were performed as in the vial assays. Results: All vials with varying dilutions of glycerin, phenol, and their combination showed bacterial growth with the standard inoculum of Staphylococcus aureus. Visible turbidity and optical density were inversely related to additive concentration. Follow-up microdilution assays with differing concentrations of bacteria demonstrated bactericidal activity with inocula of 1×10 3 colony forming units (CFU) of Staphylococcus aureus at clinically used concentrations of glycerin and phenol. Conclusion: Higher concentrations of additives show better inhibition of bacterial growth. Solutions containing glycerin showed superior bactericidal activity than those containing only phenol. At concentrations of additives used in preparing allergy immunotherapy vials, antibacterial effects were observed with inoculation of 1×10 3 CFU or less of Staphylococcus aureus.

KW - Cutaneous drug administration

KW - Drug preparation

KW - Immunologic densitization

KW - Immunotherapy

KW - In vitro

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=84862883708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862883708&partnerID=8YFLogxK

U2 - 10.1002/alr.20105

DO - 10.1002/alr.20105

M3 - Article

C2 - 22162510

AN - SCOPUS:84862883708

VL - 2

SP - 135

EP - 138

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 2

ER -